Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo

Peptide encyclopedia · Metabolic & incretin research

Semaglutide research summary

Incretin GLP-1 agonist peptide · Full compound profile

Also see the expanded Semaglutide compound database page with filters, related articles, and catalog links.

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.

Semaglutide is a GLP-1 receptor agonist peptide widely referenced in metabolic research literature. Pharmaceutical finished products exist under specific indications in some markets. VaultLabs supplies Semaglutide as a lyophilised reference material for in vitro laboratory research only. It is unrelated to Semax, an ACTH 4-10 heptapeptide analog. In the VaultLabs catalogue this is Incretin GLP-1 agonist peptide material for in vitro laboratory research, not a medicine and not a protocol.

What it is
Incretin GLP-1 agonist peptide
Category
Metabolic & incretin research
CAS
910463-68-2
Formula
C187H291N45O59
Catalogue price before VAT
30 mg at AED 649

Identity on this record

Chemical name: Semaglutide.

Common synonyms: GLP-1 receptor agonist peptide, NN9535.

CAS number: 910463-68-2 (registry entry).

Molecular formula: C187H291N45O59.

Molecular weight: 4113.58 g/mol.

Appearance: White to off-white lyophilised powder.

Catalog strength: 30 mg vial.

Those identifiers describe Semaglutide as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.

What the catalogue actually sells

Semaglutide 30mg is the 30 mg lyophilized unit, listed at AED 649 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light.

Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for Semaglutide, not a delivered-cost quote.

Lots and certificates

Lot VL-SEMA-20260801 is the catalogue certificate for Semaglutide 30mg. Read it on Semaglutide 30mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.

How the compound record describes the literature

Semaglutide entered clinical development as a long-acting GLP-1 agonist. Pharmaceutical finished products are regulated medicines; VaultLabs supplies laboratory reference material only.

Topics named on the Semaglutide record, as literature context rather than as outcomes VaultLabs claims: GLP-1 receptor binding and signalling assays; Comparative incretin peptide analytics; Stability and method development for acylated GLP-1 analogs.

That is context for identifying Semaglutide. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

Points the monograph already states

Points already written on the Semaglutide monograph, so a reader can check them against that page:

Selective GLP-1 receptor agonist; literature CAS registry number 910463-68-2.

Unrelated to Semax — different sequence class and catalog documentation.

Catalog presentation is 30 mg lyophilised research material.

Pharmaceutical semaglutide products are not the VaultLabs research SKU.

Not for human or veterinary use.

Dispatch and the research-use boundary

VaultLabs dispatches Semaglutide from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

The full narrative record is the Semaglutide compound monograph. Handling of the sealed unit is the Semaglutide storage guide. Questions are collected on the Semaglutide FAQ. How it differs from neighbouring records is the Semaglutide comparison.

Questions this page answers

What is Semaglutide on this site?

Semaglutide is a GLP-1 receptor agonist peptide widely referenced in metabolic research literature. Pharmaceutical finished products exist under specific indications in some markets. VaultLabs supplies Semaglutide as a lyophilised reference material for in vitro laboratory research only. It is unrelated to Semax, an ACTH 4-10 heptapeptide analog. VaultLabs supplies it as in vitro research material. The monograph prints CAS 910463-68-2.

Related compounds

Research tools

Catalog products

Next recommended reading

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.